These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

843 related items for PubMed ID: 16255019

  • 1. Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen.
    Auger I, Sebbag M, Vincent C, Balandraud N, Guis S, Nogueira L, Svensson B, Cantagrel A, Serre G, Roudier J.
    Arthritis Rheum; 2005 Nov; 52(11):3424-32. PubMed ID: 16255019
    [Abstract] [Full Text] [Related]

  • 2. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
    Snir O, Widhe M, von Spee C, Lindberg J, Padyukov L, Lundberg K, Engström A, Venables PJ, Lundeberg J, Holmdahl R, Klareskog L, Malmström V.
    Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
    [Abstract] [Full Text] [Related]

  • 3. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
    Xue Y, Zhang J, Chen YM, Guan M, Zheng SG, Zou HJ.
    Scand J Rheumatol; 2008 May; 37(3):183-7. PubMed ID: 18465452
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.
    Irigoyen P, Lee AT, Wener MH, Li W, Kern M, Batliwalla F, Lum RF, Massarotti E, Weisman M, Bombardier C, Remmers EF, Kastner DL, Seldin MF, Criswell LA, Gregersen PK.
    Arthritis Rheum; 2005 Dec; 52(12):3813-8. PubMed ID: 16320316
    [Abstract] [Full Text] [Related]

  • 8. The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide.
    van der Helm-van Mil AH, Verpoort KN, le Cessie S, Huizinga TW, de Vries RR, Toes RE.
    Arthritis Rheum; 2007 Feb; 56(2):425-32. PubMed ID: 17265477
    [Abstract] [Full Text] [Related]

  • 9. HLA-DRB1*0404 is strongly associated with anticalpastatin antibodies in rheumatoid arthritis.
    Auger I, Roudier C, Guis S, Balandraud N, Roudier J.
    Ann Rheum Dis; 2007 Dec; 66(12):1588-93. PubMed ID: 17324966
    [Abstract] [Full Text] [Related]

  • 10. Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations.
    van der Woude D, Lie BA, Lundström E, Balsa A, Feitsma AL, Houwing-Duistermaat JJ, Verduijn W, Nordang GB, Alfredsson L, Klareskog L, Pascual-Salcedo D, Gonzalez-Gay MA, Lopez-Nevot MA, Valero F, Roep BO, Huizinga TW, Kvien TK, Martín J, Padyukov L, de Vries RR, Toes RE.
    Arthritis Rheum; 2010 May; 62(5):1236-45. PubMed ID: 20131291
    [Abstract] [Full Text] [Related]

  • 11. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
    Snir O, Widhe M, Hermansson M, von Spee C, Lindberg J, Hensen S, Lundberg K, Engström A, Venables PJ, Toes RE, Holmdahl R, Klareskog L, Malmström V.
    Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
    [Abstract] [Full Text] [Related]

  • 12. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.
    Huizinga TW, Amos CI, van der Helm-van Mil AH, Chen W, van Gaalen FA, Jawaheer D, Schreuder GM, Wener M, Breedveld FC, Ahmad N, Lum RF, de Vries RR, Gregersen PK, Toes RE, Criswell LA.
    Arthritis Rheum; 2005 Nov; 52(11):3433-8. PubMed ID: 16255021
    [Abstract] [Full Text] [Related]

  • 13. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status.
    Bang SY, Lee KH, Cho SK, Lee HS, Lee KW, Bae SC.
    Arthritis Rheum; 2010 Feb; 62(2):369-77. PubMed ID: 20112396
    [Abstract] [Full Text] [Related]

  • 14. New classification of the shared epitope in rheumatoid arthritis: impact on the production of various anti-citrullinated protein antibodies.
    Gyetvai A, Szekanecz Z, Soós L, Szabó Z, Fekete A, Kapitány A, Teodorescu M, Sipka S, Szegedi G, Lakos G.
    Rheumatology (Oxford); 2010 Jan; 49(1):25-33. PubMed ID: 19920092
    [Abstract] [Full Text] [Related]

  • 15. Alterations of the synovial T cell repertoire in anti-citrullinated protein antibody-positive rheumatoid arthritis.
    Cantaert T, Brouard S, Thurlings RM, Pallier A, Salinas GF, Braud C, Klarenbeek PL, de Vries N, Zhang Y, Soulillou JP, Tak PP, Baeten D.
    Arthritis Rheum; 2009 Jul; 60(7):1944-56. PubMed ID: 19565497
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis.
    Michou L, Teixeira VH, Pierlot C, Lasbleiz S, Bardin T, Dieudé P, Prum B, Cornélis F, Petit-Teixeira E.
    Ann Rheum Dis; 2008 Apr; 67(4):466-70. PubMed ID: 17660221
    [Abstract] [Full Text] [Related]

  • 19. Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis.
    Verpoort KN, van Gaalen FA, van der Helm-van Mil AH, Schreuder GM, Breedveld FC, Huizinga TW, de Vries RR, Toes RE.
    Arthritis Rheum; 2005 Oct; 52(10):3058-62. PubMed ID: 16200610
    [Abstract] [Full Text] [Related]

  • 20. Hormonal replacement therapy may reduce the risk for RA in women with early arthritis who carry HLA-DRB1 *01 and/or *04 alleles by protecting against the production of anti-CCP: results from the ESPOIR cohort.
    Salliot C, Bombardier C, Saraux A, Combe B, Dougados M.
    Ann Rheum Dis; 2010 Sep; 69(9):1683-6. PubMed ID: 19740903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.